PPMS- A Detailed Overview
The report gives the overview of Primary progressive multiple sclerosis disease indication in detail, highlights the PPMS epidemiology in the key geographies, elaborates on the drugs prescribed and expected to be prescribed in PPMS and covers the detailed market sizing drug wise and country wise in value sales and patient numbers along with forecast.
Multiple Sclerosis Definition
Types of MS
SPMS definition
Causes of PPMS
Profile of PPMS patient
Symptoms of PPMS patient
Disease progression and impact on QoL
Disease diagnosis
Disease Epidemiology in key markets
Factors influencing Physician prescription decision
DMTs for PPMS
Drug Attribute analysis
Pipeline products in PPMS
PPMS Market sizing drug wise including value sales and patient numbers
Types of MS
SPMS definition
Causes of PPMS
Profile of PPMS patient
Symptoms of PPMS patient
Disease progression and impact on QoL
Disease diagnosis
Disease Epidemiology in key markets
Factors influencing Physician prescription decision
DMTs for PPMS
Drug Attribute analysis
Pipeline products in PPMS
PPMS Market sizing drug wise including value sales and patient numbers
More Publications
Migraine- Detailed overview Acute Treatments
US$ 4,000.00
December 2017
87 pages
Schizophrenia: Disease Inights and Market Forecasts to 2024
US$ 5,000.00
March 2018
120 pages
SPMS- Disease Overview, Epidemiology and Drug Overview
US$ 3,000.00
September 2017
65 pages
SPMS- Disease Overview and Epidemiology
US$ 2,000.00
September 2017
26 pages
Epilepsy: Disease Inights and Market Forecasts to 2024
US$ 5,000.00
March 2018
120 pages